Alpha 2.0
Login Register
» Articles » PMID: 13584852

Toxic Effects of Iproniazid in a Patient with Angina

Overview
Journal Br Med J
Specialty General Medicine
Date 1958 Nov 1
PMID 13584852
Citations 14
Authors
C Papp
S Benaim
Affiliations
Soon will be listed here.
Citing Articles

The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.

Jessen L, Kovalick L, Azzaro A P T. 2009; 33(4):212-46.

PMID: 19750165 PMC: 2730099.

A comparison of the effects of imipramine, trimipramine, and some other drugs in rabbits treated with a monoamine oxidase inhibitor.

Loveless A, Maxwell D Br J Pharmacol Chemother. 2008; 25(1):158-70.

PMID: 19108193 PMC: 1510676. DOI: 10.1111/j.1476-5381.1965.tb01768.x.

Dangerous potentiation of pethidine by iproniazid, and its treatment.

Shee J Br Med J. 1960; 2(5197):507-9.

PMID: 14445706 PMC: 2097120. DOI: 10.1136/bmj.2.5197.507.

PETHIDINE POISONING.

VINNICOMBE J Br Med J. 1963; 2(5361):822.

PMID: 14063919 PMC: 1872961. DOI: 10.1136/bmj.2.5361.822.

The excretion of pethidine and its derivatives.

Asatoor A, London D, Milne M, SIMENHOFF M Br J Pharmacol Chemother. 1963; 20:285-98.

PMID: 13965101 PMC: 1703639. DOI: 10.1111/j.1476-5381.1963.tb01468.x.

References
1.
Dundee J, TINCKLER L . Pethidine and liver damage. Br Med J. 1952; 2(4786):703-4. PMC: 2021548. DOI: 10.1136/bmj.2.4786.703. View
2.
OCONNOR J, HOWLETT Jr K, Wagner R . Side effects accompanying use of iproniazid. Am Rev Tuberc. 1953; 68(2):270-2. DOI: 10.1164/art.1953.68.2.270. View
3.
Fouts J, Brodie B . On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J Pharmacol Exp Ther. 1956; 116(4):480-5. View
4.
DALLY P . Indications for use of iproniazid in psychiatric practice. Br Med J. 1958; 1(5083):1338-9. PMC: 2029073. DOI: 10.1136/bmj.1.5083.1338. View
5.
COSSIO P . [Treatment of angina pectoris & other ischemic pain by iproniazid phosphate]. Rev Med Chil. 1958; 86(2):67-86. View